LA
THC icon

Lee Ainslie’s Tenet Healthcare THC Stock Holding History

Lee Ainslie’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,729
Closed -$1.18M – 325
2025
Q2 		$1.18M Hold
6,729
– – 0.02% 142
2025
Q1 		$905K Buy
6,729
+3,872
+136% +$510K 0.02% 139
2024
Q4 		$361K Sell
2,857
-4,857
-63% -$722K 0.01% 164
2024
Q3 		$1.28M Sell
7,714
-156
-2% -$23.6K 0.03% 180
2024
Q2 		$1.05M Buy
+7,870
New +$947K 0.02% 213
2024
Q1 		– Sell
-10,153
Closed -$767K – 542
2023
Q4 		$767K Buy
10,153
+3,379
+50% +$214K 0.02% 149
2023
Q3 		$446K Sell
6,774
-2,733
-29% -$204K 0.01% 188
2023
Q2 		$774K Buy
9,507
+641
+7% +$45.6K 0.02% 186
2023
Q1 		$527K Sell
8,866
-980
-10% -$54.5K 0.01% 246
2022
Q4 		$480K Buy
9,846
+2,815
+40% +$130K 0.01% 195
2022
Q3 		$363K Buy
+7,031
New +$417K 0.01% 202
2022
Q1 		– Sell
-1,750
Closed -$143K – 369
2021
Q4 		$143K Sell
1,750
-13,830
-89% -$1.01M ﹤0.01% 110
2021
Q3 		$1.03M Sell
15,580
-12,184
-44% -$864K 0.01% 303
2021
Q2 		$1.86M Buy
27,764
+24,508
+753% +$1.52M 0.02% 178
2021
Q1 		$169K Buy
3,256
+1,878
+136% +$94.9K ﹤0.01% 519
2020
Q4 		$55K Sell
1,378
-787
-36% -$25.4K ﹤0.01% 617
2020
Q3 		$53K Buy
+2,165
New +$55.3K ﹤0.01% 540
2020
Q2 		– Sell
-129,895
Closed -$1.87M – 665
2020
Q1 		$1.87M Buy
+129,895
New +$3.73M 0.04% 194
2019
Q4 		– Sell
-110,571
Closed -$2.45M – 420
2019
Q3 		$2.45M Buy
+110,571
New +$2.36M 0.04% 224
2019
Q2 		– Sell
-102,370
Closed -$2.95M – 343
2019
Q1 		$2.95M Buy
+102,370
New +$2.53M 0.04% 233
2018
Q2 		– Sell
-72,680
Closed -$1.76M – 294
2018
Q1 		$1.76M Buy
+72,680
New +$1.45M 0.02% 198

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Lee Ainslie's THC Position: Q3 2025 in Review

Lee Ainslie sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 6,729 shares — an estimated $1.18M sold.

Lee Ainslie first reported a position in THC in Q1 2018 and held it in 21 quarters. The position peaked at $2.95M in Q1 2019. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Lee Ainslie reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Lee Ainslie sold 6,729 Tenet Healthcare shares in Q3 2025, an estimated $1.18M.
  • Lee Ainslie first reported a position in Tenet Healthcare in Q1 2018 and held it in 21 quarters.
  • Lee Ainslie's Tenet Healthcare position peaked at $2.95M in Q1 2019.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Maverick Capital's 13F filing for Q3 2025, filed 14 Nov 2025.